Chelation for Heart Health - Dr. Doreen DeStefano, APRN, NhD
What you’ll learn today:
The word chelate is derived from the Greek word chele, which refers to the claw of a crab or lobster, implying a strong binding action by the chelating agent to another compound.
Chelation therapy involves administering specific agents (orally, rectally, or intravenously) to bind toxic compounds in the blood or tissues of the body.
The process of removing toxic metals and atherosclerotic plaque is known as Chelation Therapy. Most effective when administered by the intravenous route.
The origin of chelation therapy dates back to 1940, when it was first used to treat lead poisoning using EDTA. Later, it became evident that EDTA chelation therapy plays a significant role in reversing the mechanisms that promote atherosclerotic plaque formations (diseased arteries), which subsequently cause heart disease and peripheral vascular diseases.
Today, EDTA chelation therapy is administered safely by intravenous methods to help prevent and treat cardiovascular disease (heart disease and other venous or arterial disorders) and cerebrovascular disease (such as stroke and vascular dementia).
Accumulation metals from various sources and cholesterol can accumulate in the arteries and other tissues of the body. This accumulation can lead to free radical damage, micro-inflammation and increased vulnerability to infection of the blood vessels, which in turn, initiates the process of atherosclerosis leading to arteriosclerosis (narrowing of the arteries). When blood supply is reduced, the tissue affected (such as the brain, heart, kidney) will lack oxygen, and the delivery of vital nutrients and removal of waste is compromised. The affected tissue or organ begins to starve and become diseased.